Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lyvgen Biopharma Holdings Limited

Clinical trials sponsored by Lyvgen Biopharma Holdings Limited, explained in plain language.

Not yet finished but already full! 1 Completed 3

New hope for hard-to-treat head and neck cancer: triple therapy trial underway

Disease control Ongoing

This study tests a new three-drug combination for people with advanced head and neck cancer that came back or spread after platinum chemotherapy. The drugs aim to boost the immune system and attack cancer cells directly. About 64 adults will take part to see if the treatment is s…

Phase: PHASE2 • Sponsor: Lyvgen Biopharma Holdings Limited • Aim: Disease control

Last updated Jun 27, 2026 12:35 UTC